Effectiveness of Beta Blockers against Hypertrophic Cardiomyopathy
DOI:
https://doi.org/10.53350/pjmhs22162121Keywords:
Beta blockers, Cardiomyopathy, Efficacy, Therapeutic interventionsAbstract
Aim: To evaluate the effectiveness of beta blockers against hypertrophic cardiomyopathy.
Study design: Retrospective study
Place and duration of study: Department of Medicine, Islam Medical College, Sialkot from 01-10-2020 30-01-09-2021.
Methodology: One hundred and thirty six confirmed hypertrophic cardiomyopathy cases within the age of 3-75 years were enrolled. Different types of beta blocker used and its efficacy result and side effects were documented. The average efficacy was assessed for each beta blocker uptil 5 years’ survival rate.
Results: High doses of beta blocker were indicated for hypertrophic cardiomyopathy patients in majority of the cases. The efficacy of various beta blockers shows that cardio-selective blocker is much better in efficacy. Left ventricle outflow tract (LVOT) with a value greater or equal to 50 mmHg was observed in patients at or greater than 70 years.
Conclusion: Beta blockers are effective in hypertrophy cardiomyopathy cases depending upon the left ventricle out flow tract for better outcome.
Downloads
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal and all the published articles / items are distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.